In bacteria, these drugs are competitive inhibitors of para-aminobenzoic acid (PABA), necessary in these organisms for the synthesis of folic acid.
In bacteria, these drugs are competitive inhibitors of para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate syntetase. This reaction is necessary in these organisms for the synthesis of folic acid.